Genomma Lab Internacional SAB de CV  

(Public, BMV:LABB)   Watch this stock  
Find more results for Herrera
12.60
+0.06 (0.48%)
Feb 10 - Close
BMV data delayed by 20 mins - Disclaimer
Currency in MXN
Range 12.47 - 12.85
52 week 8.75 - 23.30
Open 12.77
Vol / Avg. 2.11M/3.47M
Mkt cap 13.31B
P/E 11.92
Div/yield     -
EPS 1.06
Shares 1.05B
Beta     -
Inst. own     -
Apr 13, 2016
Genomma Lab Internacional SAB de CV Annual Shareholders Meeting (Estimated) - 6:00PM CDT - Add to calendar
Feb 24, 2016
Q4 2015 Genomma Lab Internacional SAB de CV Earnings Release (Estimated) - 3:00PM CST - Add to calendar
Jan 12, 2016
Genomma Lab Internacional SAB de CV at JPMorgan Healthcare Conference
  

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 6.76% 12.95%
Operating margin 13.70% 21.19%
EBITD margin - 22.04%
Return on average assets 3.14% 6.99%
Return on average equity 6.41% 15.07%
Employees 930 -
CDP Score - -

Address

Edificio Samara Antonio Dovali Jaime no. 70 Piso 2 Colonia Santa Fe
MEXICO, D.F., 01210
Mexico
+52-55-50810000 (Phone)
+52-55-50810000 (Fax)

Website links

Description

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Officers and directors

Rodrigo Alonso Herrera Aspra Chairman of the Board
Age: 46
Maximo Juda Chief Executive Officer
Antonio Zamora Galland Executive Vice President, Chief Financial Officer
Claudia Georgina Ortega Vettoretti Executive Vice President of Marketing
Age: 49
Renata Virginia Herrera Aspra Executive Vice President of Innovation, Development and Purchases
Age: 49
Ramon Neme Sastre Executive Vice President of Institutional Relations
Age: 54
Marco Sparvieri Executive Vice-President of Global Sales
Alejandro Baston Patino Vice-President of International and Sales Development
Age: 49
Marco Francisco Forastieri Munoz Non-Member Secretary of the Board of Directors
Sabrina Lucila Herrera Aspra Director